Aramis Biosciences
Aramis Biosciences

Aramis Biosciences Information

Contact top employees from Aramis Biosciences

Summary

Aramis Biosciences is a clinical-stage immuno-ophthalmology biopharmaceutical company committed to the development of disease-modifying therapy for ocular surface disease....Show more

Industries

Biotechnology

Headquarters Location

Employees Size

1-10 employees

Founded

2018

Contact Aramis Biosciences

Organization Website

Social Links

linkedIn

Competitors

Founded
Type
Employees
Revenue
Funding
2018Privately
Held
1 - 25 6M $109.5M
2014Public
Company
25 - 100 < 1M $293M
2015Privately
Held
10-50 < 1M $1M
2015Privately
Held
1 - 25 < 1M $0
2018- 100-200 - $-
2020- 1-10 - $-
-- 1-10 - $-

Employees Turnover 3 quarter 2025

Length of Employment
arrow
Employee tenure at Aramis Biosciences shows a diverse range of experience levels:
20% for 1–2 years40% for 3–4 years40% for 5–7 years
Contact top employees from Aramis Biosciences
David Tierney
President & CEO
View
David Lacey
Chief Operating Officer
View

FAQ

Aramis Biosciences operates in the Biotechnology industries. More details can be found on the official website: aramisbio.com.
The headquarters of Aramis Biosciences are located in Boston, United States.
Aramis Biosciences currently employs 1-10 people.
Well-known competitors of Aramis Biosciences include Aro Biotherapeutics, ORIC Pharmaceuticals Inc., Saol Therapeutics and Context Therapeutics.
BACK TO TOP